➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Medtronic
Harvard Business School
Boehringer Ingelheim
McKesson

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

Prednisolone sodium phosphate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for prednisolone sodium phosphate and what is the scope of freedom to operate?

Prednisolone sodium phosphate is the generic ingredient in thirteen branded drugs marketed by Merck, Watson Labs, Novartis, Schering, Pharmafair, Akorn, Alcon Pharms Ltd, Bausch And Lomb, Sola Barnes Hind, Concordia Pharms Inc, Seton Pharm, Amneal Pharms, Chartwell Rx, Edenbridge Pharms, Medicis Pharms, Mission Pharma, Nesher Pharms, Pharm Assoc, Vintage, Vintage Pharms, We Pharms, Wockhardt Bio Ag, Mylan Pharms Inc, and Sandoz Inc, and is included in forty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are eighty-eight drug master file entries for prednisolone sodium phosphate. Twenty-one suppliers are listed for this compound.

Recent Clinical Trials for prednisolone sodium phosphate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ocular TherapeutixPhase 4
New England Retina AssociatesPhase 4
Research to Prevent BlindnessPhase 2

See all prednisolone sodium phosphate clinical trials

Pharmacology for prednisolone sodium phosphate
Paragraph IV (Patent) Challenges for PREDNISOLONE SODIUM PHOSPHATE
Tradename Dosage Ingredient NDA Submissiondate
ORAPRED ODT TABLET, ORALLY DISINTEGRATING;ORAL prednisolone sodium phosphate 021959 2010-07-22
PEDIAPRED SOLUTION;ORAL prednisolone sodium phosphate 019157

US Patents and Regulatory Information for prednisolone sodium phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate; sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 073630-001 May 27, 1993 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Merck HYDELTRASOL prednisolone sodium phosphate OINTMENT;OPHTHALMIC, OTIC 011028-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Novartis INFLAMASE FORTE prednisolone sodium phosphate SOLUTION/DROPS;OPHTHALMIC 080751-002 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for prednisolone sodium phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Concordia Pharms Inc ORAPRED ODT prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 021959-002 Jun 1, 2006   Get Started for $10   Get Started for $10
Concordia Pharms Inc ORAPRED ODT prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 021959-001 Jun 1, 2006   Get Started for $10   Get Started for $10
Seton Pharm PEDIAPRED prednisolone sodium phosphate SOLUTION;ORAL 019157-001 May 28, 1986   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Medtronic
Mallinckrodt
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.